Citizens JMP analyst Patrick Walravens lowered the firm’s price target on C3 AI (AI) to $50 from $55 and keeps an Outperform rating on the shares. The company announced “mixed” Q3 results, though guidance was mostly in line, the analyst tells investors in a research note. While C3’s founder and CEO Thomas Seibel has recently suffered a health setback that will limit his ability to travel for a time and federal government spending is uncertain in the near term, Citizens continues to like C3.ai as an opportunity for long-term capital appreciation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AI:
- C3 AI price target lowered to $21 from $29 at KeyBanc
- C3 AI price target lowered to $28 from $42 at Piper Sandler
- C3.ai’s Growth Potential Amidst Cautious Hold Rating: Analyzing Financial Performance and Market Partnerships
- Cautious Outlook: Decelerating Revenue Growth and Reliance on Demonstration Licenses Justify Sell Rating
- C3 AI price target lowered to $30 from $32 at Morgan Stanley